Hjem › Blodpropper › Tennessee
Kliniske studier for Blodpropper i Tennessee
7 studier for Blodpropper søker deltakere på steder i Tennessee.
Byer i Tennessee
Offisiell studietekst (engelsk)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Tennessee Center for Clinical Trials, Tullahoma
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- East Coast Institute for Research, Jefferson City, Jefferson City
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07175428Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Apex Research Foundation, LLC, Jackson
- Tennova TCMC, Knoxville
- Vanderbilt Heart and Vascular Tullahoma, Cardiology and Vascular Associates, Tullahoma
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07318610Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Tennessee Center for Clinical Trials, Tullahoma
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07430956ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- St. Jude Children's Research Hospital, Memphis
- Vanderbilt University Medical Center, Nashville
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628Rapid Evacuation and Access of Cerebral Hemorrhage Trial
- Vanderbilt University Medical Center, Nashville
Rekrutterer
Alder 18 til 70 · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06870812Neonatal Platelet Transfusion Threshold Trial
- Vanderbilt University, Nashville
RekruttererFrivillige helsepersonell ønskes velkommen
1 Hour – 48 Hours · Alle kjønn · Oppdatert 25. mar. 2026 · NCT06676904Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.